ITGB1 and pancreatic neoplasm: Notably, Ganguly et al. found that MUC5AC acts as a systemic carrier of tumor secretome and can alter stromal maturation in pancreatic cancer by mobilizing AD-MSCs via CD44 and CD29/ITGB1 clustering [161].